Poz.com, January 21, 2021 On January 21, the Food and Drug Administration (FDA) in the USA approved the first complete injectable HIV treatment regimen that does not require daily pills. Cabenuva, from ViiV Healthcare, is administered only once a month. It is approved for people with an undetectable viral load on their current therapy who wish to switch to a long-acting regimen. Cabenuva consists...
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study The Lancet, Published Online May 2, 2019 Background The level of evidence for HIV transmission risk through condomless sex in serodifferent gay couples with the HIV-positive...
The Conversation, 7 August 2018 By David Rhodes, Senior Lecturer, School of Education, Edith Cowan University How children are taught about sex, relationships and sexuality at school is shaping up to be a political hot potato in Australia (again). It’s already been slated to be an issue in the Victorian state elections later this year. That’s just a short time from being on the agenda during the...
SA Health / SHINE SA, October 2017 An increase in the number of notifications of hepatitis A has been reported in New South Wales amongst men who have sex with men (MSM). It is suspected that these infections are associated with a recent outbreak overseas amongst MSM in Europe and the Americas. Key prevention messages: Vaccination is the most effective form of prevention against hepatitis A...
nam/aidsmap, 01 August 2017 The stillbirth rate among women living with HIV in the UK and Ireland from 2007 to 2015 was more than twice that of the general population, Graziella Favarato, presenting on behalf of the National Study of HIV in Pregnancy and Childhood (NSHPC), told participants at the 9th International AIDS Society Conference on HIV Science (IAS 2017) in Paris last week. Most women...
BBC news, 11 May 2017 Young people on the latest HIV drugs now have near-normal life expectancy because of improvements in treatments, a new study in The Lancet suggests. Twenty-year-olds who started antiretroviral therapy in 2010 are projected to live 10 years longer than those first using it in 1996, it found. Doctors say that starting treatment early is crucial to achieve a long and healthy...